Ironwood Pharmaceuticals IRWD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $40.77M— | $0-100% | $40.08M+69.8% | $23.6M+163% | -$37.39M-1,757% | ||
| $443K-3.7% | $460K-3.2% | $475K+1.7% | $467K-2.5% | $479K-1.2% | ||
| $3.65M-4.4% | $3.82M+5.8% | $3.61M-20.2% | $4.52M-14.5% | $5.29M+15.9% | ||
| $19.2M— | $0-100% | $27.77M+96.9% | $14.11M+2,005% | $670K-98.4% | ||
| $59.1M+180% | -$73.62M-315% | $34.19M-26.3% | $46.4M+210% | -$42.12M— | ||
| -$4.89M— | $0-100% | $10.69M+177% | -$13.84M-243% | $9.66M+268% | ||
| -$6M-452% | -$1.09M-538% | $248K+288% | $64K-84.3% | $407K+118% | ||
| -$219K— | $0-100% | $249K-93.2% | $3.67M+1,862% | $187K+101% | ||
| $444K+2.1% | $435K+2.1% | $426K+1.9% | $418K+2.2% | $409K+1.7% | ||
| -$621K-1.5% | -$612K-1.5% | -$603K-3.3% | -$584K-2.1% | -$572K-1.8% | ||
| $5.12M-93.1% | $74.58M+56.7% | $47.58M— | —— | $19.95M+31.2% | ||
| —— | $0-100% | $2K0.0% | $2K-93.5% | $31K— | ||
| —— | $0+100% | -$2K0.0% | -$2K+93.5% | -$31K— | ||
| —— | $122K— | $0-100% | $88K+1,367% | $6K-97.0% | ||
| —— | $122K— | $0-100% | $88K+1,367% | $6K+100% | ||
| -$106K— | —— | -$26K+96.0% | -$647K-9,143% | -$7K— | ||
| $5.02M-93.3% | $75.05M+57.8% | $47.56M— | —— | $19.92M— | ||
| —— | $7.58M0.0% | $7.58M0.0% | $7.58M0.0% | $7.58M-6.8% | ||
| —— | $885.75K0.0% | $885.75K0.0% | $885.75K0.0% | $885.75K-57.9% | ||
| $443K-3.7% | $460K-3.2% | $475K+1.7% | $467K-2.5% | $479K-1.2% | ||
| -$1.1M-302% | -$274K+76.5% | -$1.17M+27.5% | -$1.61M-52.8% | -$1.05M+61.3% | ||
| -$621K-1.5% | -$612K-1.5% | -$603K-3.3% | -$584K-2.1% | -$572K-1.8% | ||
| -$219K— | $0-100% | $249K-93.2% | $3.67M+1,862% | $187K+101% | ||
| -$121K-21.0% | -$100K-58.7% | -$63K+55.9% | -$143K-1.4% | -$141K— | ||
| -$6M-452% | -$1.09M-538% | $248K+288% | $64K-84.3% | $407K+118% | ||
| $444K+2.1% | $435K+2.1% | $426K+1.9% | $418K+2.2% | $409K+1.7% | ||
| $419K+0.2% | $418K0.0% | $418K+0.5% | $416K0.0% | $416K+0.2% | ||
| —— | $122K— | $0-100% | $88K+1,367% | $6K-97.0% | ||
| —— | $885.75K0.0% | $885.75K0.0% | $885.75K0.0% | $885.75K-57.9% | ||
| —— | $74.58M+56.7% | $47.58M— | —— | $19.92M+31.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Ironwood Pharmaceuticals generate?
- Ironwood Pharmaceuticals (IRWD) generated $147.2M in operating cash flow over the trailing twelve months.
- Where does Ironwood Pharmaceuticals's cash flow data come from?
- Every line is extracted from Ironwood Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
